What is the typical Remicade (infliximab) price in the USA vs. Canada?
Remicade pricing is not the same across countries because it depends on factors like the negotiated payer price, infusion-center billing, dosage, and whether the patient is using a brand or a biosimilar. In many cases, the “sticker price” differs from what insurers and government programs actually pay.
Because you asked for “Remicade price USA in Canada” (which reads like a comparison), the most reliable way to answer is to look up each country’s published pricing context (U.S. pricing is often less transparent publicly; Canada can also vary by province and reimbursement rules).
Why you may see different numbers for “Remicade price” online
Even when people quote a single price, the real cost to the system can change based on:
- Dose and treatment schedule (infliximab is weight-based and given by infusion).
- Whether you’re comparing cash price versus insurance reimbursement.
- Hospital/clinic administration fees (often separate from the drug cost).
- Whether the patient is switched to an infliximab biosimilar (Canada and the U.S. both use biosimilars for infliximab in many cases).
How to estimate your actual cost in Canada (practical approach)
To estimate what Remicade will cost you in Canada, you generally need:
- Your province (drug plans and patient cost-sharing differ).
- Whether you have private insurance, employer coverage, or public coverage.
- The dose (mg/kg) and how often you’re infused.
- Whether your prescriber can use an infliximab biosimilar instead of Remicade.
Are there infliximab biosimilars in Canada that affect Remicade pricing?
In practice, biosimilars can reduce what payers cover and influence what brands like Remicade are able to charge. If your goal is the lowest real-world price, you usually need to ask your infusion center/pharmacy what infliximab product is covered under your plan in Canada (not just what Remicade costs in the abstract).
If you want a direct USA-to-Canada price comparison, what to tell me
I can give a more targeted answer if you share a few details:
1) Are you comparing the drug cost only or total infusion cost?
2) Your dosage (or weight + prescribed mg/kg) and infusion frequency.
3) Which Canadian province and whether you have public coverage or private insurance.
Source you can use for pricing/patent context
DrugPatentWatch can help with product and market context (including whether biosimilars/alternatives are in the market and related IP timelines), which affects real pricing negotiations. You can start here: DrugPatentWatch.com.
---
Sources:
1. DrugPatentWatch.com